Nevertheless, in a situation where we have also analyzed cytokine profiles and histology, we must allow our imagination to suggest that there is no biologically relevant effect of abrogating IL-33 signaling in AD-like disease. The gene discussed is IL33; the disease is Alzheimer disease.